Seguridad e inmunogenicidad de cilgavimab-tixagevimab para la profilaxis preexposición frente a la COVID-19 en pacientes inmunodeprimidos / Safety and immunogenicity of cilgavimab-tixagevimab for COVID-19 pre-exposure prophylaxis in immunocompromised patients
Med. clín (Ed. impr.)
; 160(10): 458-459, mayo 2023.
Article
in Es
| IBECS
| ID: ibc-220537
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
Search on Google
Collection:
06-national
/
ES
Database:
IBECS
Main subject:
Immunocompromised Host
/
Coronavirus Infections
/
Antibodies, Neutralizing
/
Patient Safety
/
Pre-Exposure Prophylaxis
/
Antibodies, Monoclonal
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
Language:
Es
Journal:
Med. clín (Ed. impr.)
Year:
2023
Document type:
Article